Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
NH, United States.
Department of Pediatrics, Dartmouth-Hitchcock Medical Center, NH, United States.
NH, United States.
Show others and affiliations
2023 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 14, no 1, article id 2249Article in journal (Refereed) Published
Abstract [en]

Vaccination of SARS-CoV-2 convalescent individuals generates broad and potent antibody responses. Here, we isolate 459 spike-specific monoclonal antibodies (mAbs) from two individuals who were infected with the index variant of SARS-CoV-2 and later boosted with mRNA-1273. We characterize mAb genetic features by sequence assignments to the donors' personal immunoglobulin genotypes and assess antibody neutralizing activities against index SARS-CoV-2, Beta, Delta, and Omicron variants. The mAbs used a broad range of immunoglobulin heavy chain (IGH) V genes in the response to all sub-determinants of the spike examined, with similar characteristics observed in both donors. IGH repertoire sequencing and B cell lineage tracing at longitudinal time points reveals extensive evolution of SARS-CoV-2 spike-binding antibodies from acute infection until vaccination five months later. These results demonstrate that highly polyclonal repertoires of affinity-matured memory B cells are efficiently recalled by vaccination, providing a basis for the potent antibody responses observed in convalescent persons following vaccination.

Place, publisher, year, edition, pages
Springer Nature, 2023. Vol. 14, no 1, article id 2249
National Category
Infectious Medicine Immunology in the medical area
Identifiers
URN: urn:nbn:se:umu:diva-207700DOI: 10.1038/s41467-023-37972-1ISI: 000988360100006PubMedID: 37076511Scopus ID: 2-s2.0-85152979308OAI: oai:DiVA.org:umu-207700DiVA, id: diva2:1753649
Funder
Knut and Alice Wallenberg FoundationSwedish Research Council, 2017-00968Available from: 2023-04-28 Created: 2023-04-28 Last updated: 2023-09-05Bibliographically approved

Open Access in DiVA

fulltext(1950 kB)114 downloads
File information
File name FULLTEXT01.pdfFile size 1950 kBChecksum SHA-512
dc6f58d378cce75d2c650ec16760742ea6c9f6075086eba936bcf7d4e2b206a3728ed02162628ef36f35717a936f721f54b966f479720d66196ca47baf5028ee
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Forsell, Mattias N. E.

Search in DiVA

By author/editor
Forsell, Mattias N. E.
By organisation
Department of Clinical Microbiology
In the same journal
Nature Communications
Infectious MedicineImmunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
Total: 115 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 256 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf